{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T05:26:13Z","timestamp":1777785973726,"version":"3.51.4"},"reference-count":28,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["thegreenjournal.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.radonc.2016.04.020","type":"journal-article","created":{"date-parts":[[2016,5,11]],"date-time":"2016-05-11T13:16:52Z","timestamp":1462972612000},"page":"519-524","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Motion management during SBRT for oligometastatic cancer: Results of a prospective phase II trial"],"prefix":"10.1016","volume":"119","clinical-trial-number":[{"clinical-trial-number":"nct02228356","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Robbe","family":"Van den Begin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benedikt","family":"Engels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marlies","family":"Boussaer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Dhont","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuela","family":"Burghelea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom","family":"Depuydt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth","family":"Poels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Collen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thierry","family":"Gevaert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dirk","family":"Verellen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guy","family":"Storme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johan","family":"de Mey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"De Ridder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2016.04.020_b0005","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1200\/JCO.2014.55.9567","article-title":"Radical irradiation of extracranial oligometastases","volume":"32","author":"Salama","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2016.04.020_b0010","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1016\/S1470-2045(12)70510-7","article-title":"Stereotactic body radiotherapy for oligometastases","volume":"14","author":"Tree","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2016.04.020_b0015","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.ijrobp.2011.07.020","article-title":"Radiotherapy for liver metastases: a review of evidence","volume":"82","author":"H\u00f8yer","year":"2012","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.radonc.2016.04.020_b0020","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/1748-717X-8-175","article-title":"Single-dose radiosurgical treatment for hepatic metastases \u2013 therapeutic outcome of 138 treated lesions from a single institution","volume":"8","author":"Habermehl","year":"2013","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2016.04.020_b0025","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/annonc\/mdq385","article-title":"Phase II study of helical tomotherapy for oligometastatic colorectal cancer","volume":"22","author":"Engels","year":"2011","journal-title":"Ann Oncol"},{"key":"10.1016\/j.radonc.2016.04.020_b0030","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1748-717X-7-34","article-title":"Phase II study of helical tomotherapy in the multidisciplinary treatment of oligometastatic colorectal cancer","volume":"7","author":"Engels","year":"2012","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2016.04.020_b0035","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.radonc.2014.11.005","article-title":"Impact of inadequate respiratory motion management in SBRT for oligometastatic colorectal cancer","volume":"113","author":"Van den Begin","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2016.04.020_b0040","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/01.RVI.0000142599.48497.6B","article-title":"Percutaneous placement of marking coils before stereotactic radiation therapy of malignant lung lesions","volume":"16","author":"De Mey","year":"2005","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.radonc.2016.04.020_b0045","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.ijrobp.2007.06.064","article-title":"Histopathologic consideration of fiducial gold markers inserted for real-time tumor-tracking radiotherapy against lung cancer","volume":"70","author":"Imura","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"10.1016\/j.radonc.2016.04.020_b0050","article-title":"Feasibility of markerless tumor tracking by sequential dual-energy fluoroscopy on a clinical tumor tracking system","volume":"8\u201311","author":"Dhont","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2016.04.020_b0055","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.radonc.2014.05.017","article-title":"Treating patients with real-time tumor tracking using the Vero gimbaled linac system: Implementation and first review","volume":"112","author":"Depuydt","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2016.04.020_b0060","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.radonc.2007.10.044","article-title":"Pulmonary injury and tumor response after stereotactic body radiotherapy (SBRT): results of a serial follow-up CT study","volume":"85","author":"Guckenberger","year":"2007","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2016.04.020_b0065","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.clinimag.2014.12.005","article-title":"Computed tomographic features predictive of local recurrence in patients with early stage lung cancer treated with stereotactic body radiation therapy","volume":"2","author":"Halpenny","year":"2015","journal-title":"Clin Imaging"},{"key":"10.1016\/j.radonc.2016.04.020_b0070","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ejrad.2009.10.029","article-title":"Radiation injury of the lung after stereotactic body radiation therapy (SBRT) for lung cancer: a timeline and pattern of CT changes","volume":"79","author":"Linda","year":"2011","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.radonc.2016.04.020_b0075","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.radonc.2011.12.018","article-title":"Radiographic changes after lung stereotactic ablative radiotherapy (SABR) - Can we distinguish recurrence from fibrosis? A systematic review of the literature","volume":"102","author":"Huang","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2016.04.020_b0080","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.radonc.2012.12.015","article-title":"Initial assessment of tumor tracking with a gimbaled linac system in clinical circumstances: A patient simulation study","volume":"106","author":"Depuydt","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2016.04.020_b0085","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.radonc.2014.02.018","article-title":"Intrafractional tracking accuracy in infrared marker-based hybrid dynamic tumour-tracking irradiation with a gimballed linac","volume":"111","author":"Mukumoto","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2016.04.020_b0090","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.radonc.2015.08.033","article-title":"Dynamic tumor-tracking radiotherapy with real-time monitoring for liver tumors using a gimbal mounted linac","volume":"117","author":"Iizuka","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2016.04.020_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2016.03.006","article-title":"A dosimetric comparison of real-time adaptive and non-adaptive radiotherapy: a multi-institutional study encompassing robotic, gimbaled, multileaf collimator and couch tracking","author":"Colvill","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2016.04.020_b0100","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.radonc.2015.10.011","article-title":"Apnea-like suppression of respiratory motion: first evaluation in radiotherapy","volume":"118","author":"P\u00e9guret","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2016.04.020_b0105","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ijrobp.2014.10.021","article-title":"Stereotactic body radiation therapy for oligometastases to the lung: a phase 2 study","volume":"91","author":"Nuyttens","year":"2015","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.radonc.2016.04.020_b0110","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.radonc.2015.09.008","article-title":"Local tumor control probability modeling of primary and secondary lung tumors in stereotactic body radiotherapy","volume":"118","author":"Guckenberger","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2016.04.020_b0115","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1016\/j.ijrobp.2008.03.044","article-title":"Descriptive analysis of oligometastatic lesions treated with curative-intent stereotactic body radiotherapy","volume":"72","author":"Milano","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"10.1016\/j.radonc.2016.04.020_b0120","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.radonc.2016.01.009","article-title":"Early lesion-specific 18F-FDG PET response to chemotherapy predicts time to lesion progression in locally advanced non-small cell lung cancer","volume":"118","author":"Nyg\u00e5rd","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2016.04.020_b0125","first-page":"1","article-title":"Phase II study of stereotactic body radiotherapy to primary tumor and metastatic locations in oligometastatic non-small cell lung cancer patients","author":"Collen","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1016\/j.radonc.2016.04.020_b0130","first-page":"467","article-title":"Stereotactic radiotherapy for oligometastatic cancer: a prognostic model for survival","volume":"2014","author":"De Vin","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.radonc.2016.04.020_b0135","doi-asserted-by":"crossref","first-page":"e28650","DOI":"10.1371\/journal.pone.0028650","article-title":"MicroRNA expression characterizes oligometastasis(es)","volume":"6","author":"Lussier","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.radonc.2016.04.020_b0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3748\/wjg.v20.i1.1","article-title":"Advances in radiotherapy and targeted therapies for rectal cancer","volume":"20","author":"Sermeus","year":"2014","journal-title":"World J Gastroenterol"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814016310660?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814016310660?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,12]],"date-time":"2018-09-12T04:25:42Z","timestamp":1536726342000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814016310660"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S0167814016310660"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2016.04.020","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Motion management during SBRT for oligometastatic cancer: Results of a prospective phase II trial","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2016.04.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}